PL2970463T3 - Sposoby leczenia i/lub ograniczania rozwoju cukrzycy - Google Patents
Sposoby leczenia i/lub ograniczania rozwoju cukrzycyInfo
- Publication number
- PL2970463T3 PL2970463T3 PL14709335T PL14709335T PL2970463T3 PL 2970463 T3 PL2970463 T3 PL 2970463T3 PL 14709335 T PL14709335 T PL 14709335T PL 14709335 T PL14709335 T PL 14709335T PL 2970463 T3 PL2970463 T3 PL 2970463T3
- Authority
- PL
- Poland
- Prior art keywords
- diabetes
- treating
- methods
- limiting development
- development
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Vascular Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361779508P | 2013-03-13 | 2013-03-13 | |
| EP14709335.5A EP2970463B1 (en) | 2013-03-13 | 2014-03-12 | Methods for treating and/or limiting development of diabetes |
| PCT/EP2014/054862 WO2014140113A1 (en) | 2013-03-13 | 2014-03-12 | Methods for treating and/or limiting development of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2970463T3 true PL2970463T3 (pl) | 2018-04-30 |
Family
ID=50241460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14709335T PL2970463T3 (pl) | 2013-03-13 | 2014-03-12 | Sposoby leczenia i/lub ograniczania rozwoju cukrzycy |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2970463B1 (pl) |
| JP (2) | JP6456853B2 (pl) |
| KR (1) | KR20150127717A (pl) |
| CN (1) | CN104968681B (pl) |
| DK (1) | DK2970463T3 (pl) |
| ES (1) | ES2657090T3 (pl) |
| PL (1) | PL2970463T3 (pl) |
| WO (1) | WO2014140113A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201509575D0 (en) * | 2015-06-03 | 2015-07-15 | King S College London | Diagnostic target |
| WO2017035432A1 (en) * | 2015-08-26 | 2017-03-02 | Robert Doyle | Coagonists of glucagon-like peptide 1 receptor and neuropeptide y2 receptor |
| KR102608220B1 (ko) | 2016-05-06 | 2023-11-29 | 아이오니스 파마수티컬즈, 인코포레이티드 | Glp-1 수용체 리간드 모이어티 컨쥬게이트된 올리고뉴클레오티드 및 이의 용도 |
| JP7317706B2 (ja) * | 2016-12-14 | 2023-07-31 | リガンダル インコーポレイテッド | 核酸およびタンパク質ペイロード送達のための方法および組成物 |
| CN117106024B (zh) * | 2022-10-21 | 2024-05-24 | 南京市妇幼保健院 | 一种人血清多肽agdmp1及其在改善胰岛素抵抗中的应用 |
| CN117843807B (zh) * | 2023-12-08 | 2024-10-25 | 深圳市龙华区人民医院 | 一种tmem27融合蛋白、全人源单链抗体及其筛选方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7033597B2 (en) * | 2000-10-13 | 2006-04-25 | Université de Lausanne | Intracellular delivery of biological effectors |
| US9062306B2 (en) * | 2003-04-29 | 2015-06-23 | Biocrine Ab | Methods for identifying compounds for treating type 1 diabetes |
| WO2007097751A1 (en) * | 2006-02-22 | 2007-08-30 | The Regents Of The University Of Michigan | Methods for reducing glucose intolerance by inhibiting chop |
| WO2010083615A1 (en) * | 2009-01-26 | 2010-07-29 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing apolipoprotein c-iii expression |
| BR112013008957A2 (pt) * | 2010-10-15 | 2019-09-24 | Univ Cornell | composições e métodos para tratamento de doenças endócrinas, gastrointestinais ou autoimunes |
| US8557513B2 (en) * | 2011-06-27 | 2013-10-15 | Biocrine Ab | Methods for treating and/or limiting development of diabetes |
-
2014
- 2014-03-12 WO PCT/EP2014/054862 patent/WO2014140113A1/en not_active Ceased
- 2014-03-12 DK DK14709335.5T patent/DK2970463T3/en active
- 2014-03-12 EP EP14709335.5A patent/EP2970463B1/en active Active
- 2014-03-12 JP JP2015562130A patent/JP6456853B2/ja active Active
- 2014-03-12 CN CN201480006859.1A patent/CN104968681B/zh active Active
- 2014-03-12 KR KR1020157029030A patent/KR20150127717A/ko not_active Ceased
- 2014-03-12 PL PL14709335T patent/PL2970463T3/pl unknown
- 2014-03-12 ES ES14709335.5T patent/ES2657090T3/es active Active
-
2018
- 2018-12-19 JP JP2018236903A patent/JP7111605B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2657090T3 (es) | 2018-03-01 |
| HK1212999A1 (en) | 2016-06-24 |
| JP7111605B2 (ja) | 2022-08-02 |
| JP2019065025A (ja) | 2019-04-25 |
| CN104968681A (zh) | 2015-10-07 |
| DK2970463T3 (en) | 2018-01-22 |
| JP6456853B2 (ja) | 2019-01-23 |
| JP2016517400A (ja) | 2016-06-16 |
| EP2970463B1 (en) | 2017-11-29 |
| KR20150127717A (ko) | 2015-11-17 |
| EP2970463A1 (en) | 2016-01-20 |
| WO2014140113A1 (en) | 2014-09-18 |
| CN104968681B (zh) | 2020-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2518286B (en) | Security device and method of manufacture | |
| GB201320723D0 (en) | Composition and methods of treatment | |
| EP2991600A4 (en) | MICRO-CLOSURES AND ASSOCIATED METHODS FOR TREATING SKIN | |
| SG11201601412XA (en) | Compositions and methods for the treatment of presbyopia | |
| PT2948448T (pt) | Análogos de tiadiazol e o seu uso para tratamento de doenças associadas a uma deficiência de neurónios motores smn | |
| GB2513304B (en) | Peripheral apparatus and method of construction | |
| IL244268A0 (en) | Heterocyclic compounds and methods of use | |
| PL2970463T3 (pl) | Sposoby leczenia i/lub ograniczania rozwoju cukrzycy | |
| PL2936151T3 (pl) | Sposoby leczenia i/lub ograniczania rozwoju cukrzycy | |
| PL3074038T3 (pl) | Sposób leczenia nefropatii cukrzycowej | |
| LT3074033T (lt) | Junginiai, skirti nutukimo gydymui ir jų panaudojimo būdai | |
| PL3065751T3 (pl) | Sposób leczenia raka i chorób współistniejących | |
| IL241096B (en) | Treatment methods | |
| GB201311984D0 (en) | Methods and compounds for preventing or treating osteoarthritis | |
| SI2992094T1 (sl) | Sestavki in postopki za zdravljenje diabetesa tipa 1 | |
| ZA201601626B (en) | Treatment of gases | |
| HRP20181181T1 (hr) | Postupak obrade i liječenja lišmenioze uporabom feksinidazola | |
| IL245675A0 (en) | Therapeutic regimen and method for treating type 2 diabetes | |
| GB201322778D0 (en) | Method of treatment | |
| GB201314882D0 (en) | Method of treatment | |
| GB201321848D0 (en) | Lock means and method of use thereof | |
| ZA201302565B (en) | Methods for treating hyperuricemia and related diseases | |
| GB201302105D0 (en) | Cover Means and Method of Use Thereof | |
| AU2013904467A0 (en) | Regimen and method for treatment of type 2 diabetes |